Cargando…
Metachronous pancreatic metastases from renal cell carcinoma: is there a place of Active-Surveillance before deferred deliberately Molecular Target Agent?
BACKGROUND: Metastatic renal cell cancer is a heterogeneous disease due to its diverse morphological features, the prognostic categories based on clinical criteria. Sometimes indolent course without any significant symptoms can be differentiated before the introduction of novel targeted agents. This...
Autores principales: | Sbitti, Yassir, Seddik, Hassan, Debbagh, Adil, Benani, Fahd, Slimani, Khaoula, Mahi, Mohamed, Tarchouli, Mohamed, Aitali, Abdelmounaim, Albouzidi, Abderrahmane, Errihani, Hassan, Ichou, Mohamed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4995784/ https://www.ncbi.nlm.nih.gov/pubmed/27553296 http://dx.doi.org/10.1186/s12957-016-0939-9 |
Ejemplares similares
-
Renal damage induced by pemetrexed causing drug discontinuation: a case report and review of the literature
por: Sbitti, Yassir, et al.
Publicado: (2017) -
When tyrosine kinase inhibitor sunitinib can be discontinued in metastatic renal cell carcinoma to pancreas: a case report
por: Sbitti, Yassir, et al.
Publicado: (2018) -
Is there any advantage to combined trastuzumab and chemotherapy in perioperative setting her 2neu positive localized gastric adenocarcinoma?
por: Sbitti, Yassir, et al.
Publicado: (2011) -
Visceral Crisis Means Short Survival Among Patients With Luminal A Metastatic Breast Cancer: A Retrospective Cohort Study
por: Sbitti, Yassir, et al.
Publicado: (2017) -
Treatment of Liver Metastases From Colorectal Cancer: Medico-Surgical Strategies
por: Essadi, Ismail, et al.
Publicado: (2011)